AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PARADIGM BIOPHARMACEUTICALS

0.245

0.000

Volume:- -

Turnover:- -

Market Cap:148.68M

PE:-1.61

High:0.245

Open:0.245

Low:0.245

Close:0.245

52wk High:0.470

52wk Low:0.135

Shares:606.85M

Float Shares:353.07M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.152

EPS(LYR):-0.152

ROE:-456.96%

ROA:-138.75%

PB:42.84

PE(LYR):-1.61

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+1.43%

Capital Flow

Inflow:

Outflow:

News

Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration

Paradigm Biopharmaceuticals Ltd-Board Initiates Voluntary Administration

THOMSON REUTERS

Paradigm Biopharmaceuticals - Board Intends to Develop Proposal for Deed of Company Arrangement

THOMSON REUTERS

Paradigm Biopharmaceuticals - Clinical Review and Restructuring Process Expected to Take at Least Eight Weeks

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/PAR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PAR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","market":"AU","secType":"STK","nameCN":"PARADIGM BIOPHARMACEUTICALS","latestPrice":0.245,"timestamp":1790748720000,"preClose":0.245,"halted":3,"volume":0,"delay":0,"changeRate":0,"nameEN":"PARADIGM BIOPHARMACEUTICALS","floatShares":353065639,"shares":606848701,"eps":-0.152232,"marketStatus":"Halted","change":0,"latestTime":"09-30 16:12:00 AEST","open":0.245,"high":0.245,"low":0.245,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.152232,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.245,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PAR.AU","preClose":0.245,"auctionPrice":0.255,"auctionVolume":69,"auction":1,"marketStatus":"盘前竞价","timestamp":1790118118758}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","floatShares":353065639,"roa":"-138.75%","roe":"-456.96%","lyrEps":-0.152232,"shares":606848701,"dividePrice":0,"high":0.245,"amplitude":0,"preClose":0.245,"low":0.245,"week52Low":0.135,"pbRate":"42.84","psRate":"17595.02","week52High":0.47,"institutionHeld":0,"latestPrice":0.245,"eps":-0.152232,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.152232,"open":0.245,"prevYearClose":0.34,"prevWeekClose":0.245,"prevMonthClose":0.245,"prevQuarterClose":0.245,"fiveDayClose":0.245,"twentyDayClose":0.22,"sixtyDayClose":0.17,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-02-06","symbol":"PAR.AU","defaultRemindTime":1738796400000,"type":"split","dateTimestamp":1738760400000,"forFactor":4,"toFactor":5,"ratio":0.8},{"market":"AU","date":"2022-08-17","symbol":"PAR.AU","defaultRemindTime":1660694400000,"type":"split","dateTimestamp":1660658400000,"forFactor":992772,"toFactor":1000000,"ratio":0.992772}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PAR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671223116","title":"Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2671223116","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671223116?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:52","pubTimestamp":1790725977,"startTime":"0","endTime":"0","summary":"BRIEF-Paradigm Biopharmaceuticals Says Board Initiates Voluntary AdministrationSept 30 (Reuters)-Paradigm Biopharmaceuticals LtdPAR.AX:INITIATES VOLUNTARY ADMINISTRATION PROCESSBOARD INTENDS TO DEVELO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration","news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671997223","title":"Paradigm Biopharmaceuticals Ltd-Board Initiates Voluntary Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2671997223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671997223?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PAR.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671722391","title":"Paradigm Biopharmaceuticals - Board Intends to Develop Proposal for Deed of Company Arrangement","url":"https://stock-news.laohu8.com/highlight/detail?id=2671722391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671722391?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PAR.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671322394","title":"Paradigm Biopharmaceuticals - Clinical Review and Restructuring Process Expected to Take at Least Eight Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671322394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671322394?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","PAR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PAR.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.014295}]}}